Colour enhancement

From PsychonautWiki
Jump to navigation Jump to search

Colour enhancement is defined as an intensification of the brightness and vividness of colors in the external environment. During this experience, reds may seem “redder”, greens may seem “greener", and all colors will likely appear much more distinct, complex, and visually intense than they comparatively would be during everyday sober living.[1][2][3][4][5][6][7][8] At higher levels, this effect can sometimes result in seeing colours which are perceived as surreal or seemingly impossible.[3][4]

Colour enhancement is often accompanied by other coinciding effects such as acuity enhancement and pattern recognition enhancement.[1][2] It is most commonly induced under the influence of mild dosages of psychedelic compounds, such as LSD, psilocybin, and mescaline. However, it can also occur to a lesser extent under the influence of certain stimulants and dissociatives such as MDMA, ketamine[9], or 3-MeO-PCP.

Image examples

 Caption
2C-D
GABAergic hallucinogens
Phenethylamine (compound)
LSM-775
Paradise island by Xanny.jpgParadise island by Subsentience
4-AcO-MET
2C-H
DOI
Experience:3g mimosa / 3g syrian rue - Connecting with my body
Oxiracetam
Experience:225ug LSD + 9g cubensis - Galactic Melt and the Meverse
Experience:~150mg MDA(oral) - a case of mistaken identity
Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death
TMA-2
25N-NBOMe
Experience:300mg DXM + 25mg DMT + Cannabis - A crazy night
LSZ
2C-B
5-MeO-MiPT
ALD-52
Experience:25mg 3-MeO-PCP - Enhanced film experience
Experience:BK-2C-B - Various experiences
Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)
Bromo-DragonFLY
LSA
Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us
Experience:800 seeds LSA - My First Trip Ever
4-AcO-DMT
Experience:2C-P (approx. 35mg) - Asymmetrical Terror and the Geometric Sea
THJ-018
2C-T-21
Enhancement of colour rose.jpgRose by Chelsea Morgan
Experience:1000 Morning Glory seeds - Rediscovering the Self
PRO-LAD
Methallylescaline
Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams)
3-MeO-PCE
Enhancement of colours - woods.jpgThe Woods by Chelsea Morgan
25I-NBOMe
MDA
Chameleon.jpgChameleon by Anonymous.
Allylescaline
Pregabalin
Cannabis
25I-NBOH
5-Hydroxytryptophan
1B-LSD
3-MMC
2C-I
4-HO-DPT
Experience:4x 200ug tabs - You do not need to understand
MiPT
6-APDB
Experience:40mg - Brothermind and the Forest's Hand
MDEA
2C-T-2
JWH-073
Tree.jpgJapanese Garden by Anonymous
DOB
3C-E
DOC
4-HO-DET
Experience:3-MeO-PCP - Extreme psychosis
Experience:337mg DMT fumarate - A Day With DMT
Experience:4-HO-MiPT / A care free psychedelic getaway
MPT
Mescaline
4-AcO-DiPT
ΑMT
2C-C
4-HO-DiPT
Experience:4.5g - The Grand Introduction to Beauty and Fear
Efavirenz
THJ-2201
2C-T-7
5F-PB-22
Amanita muscaria
Experience:225mg Pregabalin +Cannabis -Bliss and Serenity; a hedonistic evening
Phenylpiracetam
MiPLA
JWH-018
AL-LAD
Experience:25mg Deschloroketamine - My first time orally dosing DCK
Experience:A combination of DOC, 5-MAPB, 5-MeO-DMT, ETH-LAD, Cannabis, Pentedrone
Experience: 5-EAPB (60mg) + 2-FMA (20mg) + 4-AcO-DMT (10mg) - Emotional catharsis
25D-NBOMe
2C-P
EPT
2C-E
Aniracetam
DMT
4-FA
4-HO-MET
PARGY-LAD
DiPT
Experience:4-AcO-DMT + 200mg Pill
Escaline
Psilocybin mushrooms
Ibogaine
Experience:5.3g psilocybe cubensis - Dimensional Circumstance and the Fabric of Understanding
Coluracetam
Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus
Experience:2.5g Syrian rue + 6g Mimosa Hostilis - Becoming God (my second experience with unity)
Ayahuasca
Experience:300µg LSD - Togetherness and the Silent Dusk
Experience:75mg 3-FMA - Perfect Blend of Euphoria and Functionality
Selective serotonin reuptake inhibitor
MET
DET
Proscaline
Piracetam
Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
Experience:Unknown dosage / 1 tab DOC - Psychedelia Turned Into Stimulant Psychosis
4-HO-MPT
Βk-2C-B
Enhancementofcolour.jpgShowing differences by Chelsea Morgan
Experience:1050 µg 1cP-LSD - The matrix
Experience:250mg DXM - DXM Itch and Trip Report
1P-LSD
Experience:120mg - Garden of The Gods
1P-ETH-LAD
LSD
ETH-LAD
Chur City in Switzerland.jpgChur, Switzerland by Naps284
5-MeO-DiBF
4-AcO-DET
4-HO-EPT
Pramiracetam
Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
Experience:1mg 25c-NBOMe - Experiment in my room
Psilocin
MDMA
4-HO-MiPT
5-MeO-DALT
25B-NBOH
TMA-6
4-AcO-MiPT
6-APB
5-MeO-DiPT
Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
Bufotenin
Omberacetam
Experience:2 tabs DOB - My DOB Nightmare
25C-NBOH
Memantine
DOM
MDAI
25B-NBOMe
2C-B-FLY
Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
DPT
Experience:300µg AL-LAD - Don't worry, because you're everyone!
25C-NBOMe

Psychoactive substances

Compounds within our psychoactive substance index which may cause this effect include:

... further results

Experience reports

Annectdotal reports which describe this effect with our experience index include:

See also

External links

References

  1. 1.0 1.1 Papoutsis, Ioannis; Nikolaou, Panagiota; Stefanidou, Maria; Spiliopoulou, Chara; Athanaselis, Sotiris (2014). "25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers". Forensic Toxicology. 33 (1): 1–11. doi:10.1007/s11419-014-0242-9. ISSN 1860-8965. 
  2. 2.0 2.1 Bersani, Francesco Saverio; Corazza, Ornella; Albano, Gabriella; Valeriani, Giuseppe; Santacroce, Rita; Bolzan Mariotti Posocco, Flaminia; Cinosi, Eduardo; Simonato, Pierluigi; Martinotti, Giovanni; Bersani, Giuseppe; Schifano, Fabrizio (2014). "25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug". BioMed Research International. 2014: 1–6. doi:10.1155/2014/734749. ISSN 2314-6133. 
  3. 3.0 3.1 Hartman, Alan M.; Hollister, Leo E. (1963). "Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception". Psychopharmacologia. 4 (6): 441–451. doi:10.1007/BF00403349. ISSN 0033-3158. 
  4. 4.0 4.1 Kleinman, J. E.; Gillin, J. C.; Wyatt, R. J. (1977). "A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*". Schizophrenia Bulletin. 3 (4): 560–586. doi:10.1093/schbul/3.4.560. ISSN 0586-7614. 
  5. . doi:10.3389/Ffnhum.2015.00346.  Missing or empty |title= (help)
  6. Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42. http://bsphs.org/wp-content/uploads/2017/04/Angelova.pdf
  7. Abraham, Henry David (1983). "Visual Phenomenology of the LSD Flashback". Archives of General Psychiatry. 40 (8): 884. doi:10.1001/archpsyc.1983.01790070074009. ISSN 0003-990X. 
  8. Baggott, M.J.; Coyle, J.R.; Erowid, E.; Erowid, F.; Robertson, L.C. (2011). "Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire". Drug and Alcohol Dependence. 114 (1): 61–67. doi:10.1016/j.drugalcdep.2010.09.006. ISSN 0376-8716. 
  9. Dillon, P (2003). "Patterns of use and harms associated with non-medical ketamine use". Drug and Alcohol Dependence. 69 (1): 23–28. doi:10.1016/S0376-8716(02)00243-0. ISSN 0376-8716.